Literature DB >> 30445448

The impact of the General Data Protection Regulation on health research.

Victoria Chico1.   

Abstract

Background: On the May 25, 2018 the General Data Protection Regulation (hereafter the GDPR or the Regulation) came into force, replacing the Data Protection Directive 95/46/EC (upon which the Data Protection Act 1998 is based), and imposing new responsibilities on organizations which process the data of European Union citizens. Sources of data: This piece examines the impact of the Regulation on health research. Areas of agreement: The Regulation seeks to harmonize data privacy laws across Europe, to protect and empower all EU citizen's data privacy and to reshape the way that organizations approach data privacy (See the GDPR portal at: https://www.eugdpr.org/ (accessed 8 May 2018). As a Regulation the GDPR is directly applicable in all member states as opposed to a directive which requires national implementing measures (In the UK the Data Protection Act 1998 was the implementing legislation for the Data Protection Directive 95/46/EC.). Areas of controversy: The Regulation is sector wide, but its impact on organizations us sector specific. In some sectors, the Regulation inhibits the processing of personal data, whilst in others it enables that processing. The Regulation takes the position that the 'processing of data should be designed to serve mankind' (Recital 4). Whilst it does not spell out what exactly is meant by this, it indicates that a proportionate approach will be taken to the protection of personal data, where that data can be processed for common goods such as healthcare. Thus, the protection of personal data is not absolute, but considered in relation to its function in society and balance with other fundamental rights in accordance with the principle of proportionality (Recital 4). Differing interpretations of proportionality can detract from the harmonization objective of the Regulation. Growing points: Reflecting the commitment to proportionality, scientific research holds a privileged position in the Regulation. Throughout the Regulation provision is made for organizations that process personal data for scientific research purposes to avoid restrictive measures which might impede the increase of knowledge. However, the application of the Regulation differs across health research sectors and across jurisdictions. Transparency and engagement across the health research sector is required to promote alignment. Areas timely for developing research: Research which focuses on the particular problems which arise in the context of the regulation's application to health research would be welcome. Particularly in the context of the operation of the Regulation alongside the duty of confidentiality and the variation in approaches across Member States.

Mesh:

Year:  2018        PMID: 30445448     DOI: 10.1093/bmb/ldy038

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  8 in total

Review 1.  Real-world evidence in rheumatic diseases: relevance and lessons learnt.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2019-02-06       Impact factor: 2.631

2.  Challenges and opportunities for Multi-National Investigator-Initiated clinical trials for ALS: European and United States collaborations.

Authors:  Paul Lingor; Jan C Koch; Jeffrey M Statland; Sumaira Hussain; Christiane Hennecke; Joanne Wuu; Thomas Langbein; Raees Ahmed; René Günther; Benjamin Ilse; Jan Kassubek; Katja Kollewe; Josua Kuttler; Andreas Leha; Teresa Lengenfeld; Thomas Meyer; Christoph Neuwirth; Ralf Tostmann; Michael Benatar
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2021-02-03       Impact factor: 3.528

3.  Ongoing debate on data governance principles for achieving Universal Health Coverage: a proposal to post-G20 Osaka Summit meetings.

Authors:  Shuhei Nomura; Haruka Sakamoto; Aya Ishizuka; Yasushi Katsuma; Hidechika Akashi; Hiroaki Miyata
Journal:  Glob Health Action       Date:  2020-12-31       Impact factor: 2.640

Review 4.  Artificial intelligence and computational pathology.

Authors:  Miao Cui; David Y Zhang
Journal:  Lab Invest       Date:  2021-01-16       Impact factor: 5.662

5.  Collaborative Research and Development of a Novel, Patient-Centered Digital Platform (MyEyeSite) for Rare Inherited Retinal Disease Data: Acceptability and Feasibility Study.

Authors:  Rose M Gilbert; Dayyanah Sumodhee; Nikolas Pontikos; Catherine Hollyhead; Angus Patrick; Samuel Scarles; Sabrina Van Der Smissen; Rodrigo M Young; Nick Nettleton; Andrew R Webster; Jocelyn Cammack
Journal:  JMIR Form Res       Date:  2022-01-31

6.  Big data and predictive analytics in healthcare in Bangladesh: regulatory challenges.

Authors:  Shafiqul Hassan; Mohsin Dhali; Fazluz Zaman; Muhammad Tanveer
Journal:  Heliyon       Date:  2021-05-29

7.  A pilot study of the depression, anxiety and stress in Greek military personnel during the first year of the COVID-19 pandemic.

Authors:  Athanasios S Kotoulas; D Karamanavis; G Ι Lambrou; P Karanikas
Journal:  BMJ Mil Health       Date:  2021-07-15

8.  From 'Consent or Anonymise' to 'Share and Protect': Facilitating Access to Surplus Tissue for Research Whilst Safeguarding Donor Interests.

Authors:  Catherine Blewett
Journal:  Health Care Anal       Date:  2021-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.